PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit
PRGONEW YORK, Dec. 5, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the "Class Period"), of the important January 16, 2026...
PRGO ALERT: Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Perrigo Company plc Investors
PRGONEW YORK--(BUSINESS WIRE)---- $PRGO #classactionlawsuit--The law firm of Kirby McInerney LLP announces that a class action lawsuit has been filed on behalf of investors who acquired Perrigo Company plc (“Perrigo” or the “Company”) (NYSE:PRGO) securities during the period of February 27, 2023 through November 4, 2025, inclusive (“the Class Period”). If you suffered a loss on your Perrigo investments, you have until January 16, 2026 to request lead plaintiff appointment. For more information: [CONTACT THE FIRM IF YOU SUFFERED
Levi & Korsinsky Notifies Perrigo Company plc Investors of a Class Action Lawsuit and Upcoming Deadline - PRGO
PRGONEW YORK, Dec. 5, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Perrigo Company plc ("Perrigo Company plc" or the "Company") (NYSE: PRGO) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Perrigo Company plc...
PRGO INVESTOR DEADLINE: Robbins Geller Rudman & Dowd LLP Announces that Perrigo Company plc Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit
PRGOSAN DIEGO, Dec. 3, 2025 /PRNewswire/ -- Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Perrigo Company plc (NYSE: PRGO) securities between February 27, 2023 and November 4, 2025, inclusive (the "Class Period"), have until January 16, 2026 to seek appointment as...
PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit
PRGONEW YORK, Dec. 1, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the "Class Period"), of the important January 16, 2026...
PRGO Investors Have Opportunity to Lead Perrigo Company plc Securities Fraud Lawsuit
PRGONEW YORK, Nov. 19, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers of securities of Perrigo Company plc (NYSE: PRGO) between February 27, 2023 and November 4, 2025, both dates inclusive (the "Class...
PRGO INVESTOR ALERT: Perrigo Company plc Investors with Substantial Losses Have Opportunity to Lead the Perrigo Class Action Lawsuit
PRGOSAN DIEGO, Nov. 18, 2025 /PRNewswire/ --Robbins Geller Rudman & Dowd LLP announces that purchasers or acquirers of Perrigo Company plc (NYSE: PRGO) securities between February 27, 2023 and November 4, 2025, inclusive (the "Class Period"), have until January 16, 2026 to seek appointment as...
Rosen Law Firm Urges Perrigo Company plc (NYSE: PRGO) Investors with Large Losses to Contact the Firm for Information About Their Rights
PRGONEW YORK--(BUSINESS WIRE)--Rosen Law Firm, a global investor rights law firm, announces a class action lawsuit on behalf of purchasers and acquirers of Perrigo Company plc (NYSE: PRGO) securities between February 27, 2023 and November 4, 2025, both dates inclusive (the “Class Period”). Perrigo provides over-the-counter health and wellness solutions. For more information, submit a form, email attorney Phillip Kim, or give us a call at 866-767-3653. The Allegations: Rosen Law Firm is Investigatin
Law Offices of Howard G. Smith Encourages Perrigo Company plc (PRGO) Shareholders to Inquire About Securities Fraud Class Action
PRGOBENSALEM, Pa.--(BUSINESS WIRE)--Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Perrigo Company plc (“Perrigo” or the “Company”) (NYSE: PRGO) securities between February 27, 2023 and November 4, 2025, inclusive (the “Class Period”). Perrigo investors have until January 16, 2025 to file a lead plaintiff motion. IF YOU ARE AN INVESTOR WHO SUFFERED A LOSS IN PERRIGO COMPANY PLC (PRGO), CONTACT THE LAW OFFICES OF HOWARD G. SMI
Investor Alert: Robbins LLP Informs Investors of the Perrigo Company Plc Class Action
PRGOSAN DIEGO, Nov. 18, 2025 /PRNewswire/ -- Robbins LLP informs stockholders that a class action was filed on behalf of all investors who purchased or otherwise acquired Perrigo Company plc (NYSE: PRGO) securities between February 27, 2024 and November 4, 2025. Perrigo provides...
Perrigo to Attend Barclays 18th Annual Global Consumer Staples Conference
PRGODUBLIN, Aug. 20, 2025 /PRNewswire/ -- Perrigo Company plc (NYSE: PRGO), a leading provider of Consumer Self-Care Products, today announced that President and CEO Patrick Lockwood-Taylor and CFO Eduardo Bezerra are scheduled to participate in one-on-one investor meetings at the Barclays...
Perrigo Widens FY2025 Adj EPS Guidance from $2.90-$3.10 to $2.29-$3.10 vs $2.99 Est; Widens FY2025 Sales Guidance from $4.42B-$4.50B to $4.37B-$4.50B vs $4.44B Est
PRGOPerrigo Q1 Adj. EPS $0.60 Beats $0.55 Estimate, Sales $1.04B Miss $1.09B Estimate
PRGOTrump Tariffs Could Have 'Significant Impact' On Perrigo Earnings, Says JP Morgan
PRGOJP Morgan warns tariffs could impact Perrigo's near-term earnings, though efficiencies and price hikes may ease pressure by 2026.
Perrigo Outlines 2025 Growth Plans, Projects Sales Boost And Margin Expansion By 2027
PRGOPerrigo Company shares surged after issuing financial targets for 2025 & 2025-2027 on investor day. Expect sales growth, EPS, and margin expansion. 'Three-S' plan will enhance cash flow & shareholder return. Q4 results below estimates.
Perrigo Co Projected FY25-FY27 Organic Net Sales CAGR Of 2.5%-4.5%, Adj EPS CAGR Of High-Single To Low-Double Digit Percentage
PRGOPerrigo Co Expects FY25 Sales Growth Of 1%-3% Vs $4.79B Est, Adj EPS Of $2.90-$3.10 Vs $3.36 Est
PRGOPerrigo Q4 2024 Adj EPS $0.93 Misses $0.94 Estimate, Sales $1.14B Miss $1.20B Estimate
PRGOPerrigo Increases Quarterly Dividend From $0.276 To $0.29 Per Share
PRGOPerrigo Reaches $98M Settlement With D&O Insurers To Resolve Coverage Dispute Over 2015-2017 Securities Litigation, Reimbursing Legal And Settlement Costs Before Year-End
PRGOPerrigo Now Expects FY24 Organic Net Sales And Reported Net Sales Outlooks Towards Lower End Of Its Previously Stated Ranges
PRGOPerrigo Reaffirms FY24 Adjusted EPS Outlook Of $2.50 - $2.65, Est $2.57
PRGOPerrigo Q3 2024 Adj EPS $0.81 Misses $0.82 Estimate, Sales $1.09B Miss $1.13B Estimate
PRGODonald J. Trump Posts On Truth I HAVE NEVER, AND WILL NEVER ADVOCATE IMPOSING RESTRICTIONS ON BIRTH CONTROL, or other contraceptives. This is a Democrat fabricated lie, MISINFORMATION/DISINFORMATION, because they have nothing else to run on except FAILURE
PRGOArgus Research Upgrades Perrigo to Buy, Announces $46 Price Target
PRGOFDA Schedules AdComm Review For First Over The Counter Birth Control Pill
PRGOPerrigo Announces Joint FDA Advisory Committee To Review Opill Daily Oral Contraceptive For Over-the-counter Use
PRGORaymond James Maintains Outperform on Perrigo, Lowers Price Target to $48
PRGO